New treatment for people with Parkinson's.
D000932:Antiemetics / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001058:Apomorphine / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D000932:Antiemetics; D000978:Antiparkinson Agents; D001058:Apomorphine